CTSO Financials 07/15/2014 19:41:47
Cytosorbents Corp
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,423 1,343 36 -
Cost of Revenue 1,912 319 12 -
Gross Profit 511 1,024 24 -
Operating Expenses
Research and Development 1,739 2,532 2,888 1,757
Sales, General and Admin. 2,577 1,355 1,230 759
Non-Recurring Items 909 627 343 307
Other - - - -
Operating Income (4,713) (3,491) (4,437) (2,824)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (5,136) (4,055) (5,482) (2,909)
Interest Expense - - - -
Earnings Before Tax (5,136) (4,055) (5,482) (2,909)
Income Tax (458) (392) - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,678) (3,664) (5,482) (2,909)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,678) (3,664) (5,482) (2,909)
Preferred Stock and Other Adjustments (2,396) (2,511) (3,087) (2,177)
Net Income Applicable to Common Shareholders (7,073) (6,175) (8,569) (5,086)